New Nordic Healthbrands Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for New Nordic Healthbrands.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Personal Products earnings growth | 7.9% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
New Nordic Healthbrands AB (publ) (STO:NNH) Stock Rockets 30% But Many Are Still Ignoring The Company
Apr 30
Does New Nordic Healthbrands (STO:NNH) Have A Healthy Balance Sheet?
Mar 19New Nordic Healthbrands (STO:NNH) Is Carrying A Fair Bit Of Debt
Nov 05New Nordic Healthbrands AB (publ)'s (STO:NNH) Popularity With Investors Is Clear
Jul 03New Nordic Healthbrands (STO:NNH) Is Making Moderate Use Of Debt
Jan 03Does New Nordic Healthbrands (STO:NNH) Have A Healthy Balance Sheet?
Sep 20Is New Nordic Healthbrands (STO:NNH) A Risky Investment?
May 10Is New Nordic Healthbrands (STO:NNH) Using Too Much Debt?
Dec 27Calculating The Fair Value Of New Nordic Healthbrands AB (publ) (STO:NNH)
Sep 15Capital Allocation Trends At New Nordic Healthbrands (STO:NNH) Aren't Ideal
Jul 30New Nordic Healthbrands (STO:NNH) Has A Pretty Healthy Balance Sheet
May 20Capital Investment Trends At New Nordic Healthbrands (STO:NNH) Look Strong
Apr 29Is New Nordic Healthbrands (STO:NNH) Using Too Much Debt?
Feb 16These 4 Measures Indicate That New Nordic Healthbrands (STO:NNH) Is Using Debt Reasonably Well
Oct 30New Nordic Healthbrands (STO:NNH) Will Be Hoping To Turn Its Returns On Capital Around
Jul 31Calculating The Intrinsic Value Of New Nordic Healthbrands AB (publ) (STO:NNH)
Jun 08Estimating The Fair Value Of New Nordic Healthbrands AB (publ) (STO:NNH)
Mar 08These 4 Measures Indicate That New Nordic Healthbrands (STO:NNH) Is Using Debt Reasonably Well
Feb 15
What Do The Returns On Capital At New Nordic Healthbrands (STO:NNH) Tell Us?
Jan 25Should New Nordic Healthbrands AB (publ) (STO:NNH) Be Part Of Your Dividend Portfolio?
Dec 31New Nordic Healthbrands AB (publ)'s (STO:NNH) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Dec 09In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as New Nordic Healthbrands has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2025 | 564 | -2 | 1 | 4 | N/A |
| 12/31/2024 | 550 | -8 | -10 | -5 | N/A |
| 9/30/2024 | 543 | -15 | -12 | -7 | N/A |
| 6/30/2024 | 549 | -12 | -9 | -6 | N/A |
| 3/31/2024 | 538 | -10 | 2 | 5 | N/A |
| 12/31/2023 | 534 | -6 | 25 | 28 | N/A |
| 9/30/2023 | 503 | -4 | 18 | 21 | N/A |
| 6/30/2023 | 490 | 1 | 15 | 18 | N/A |
| 3/31/2023 | 490 | -3 | -8 | -5 | N/A |
| 12/31/2022 | 488 | -3 | -18 | -15 | N/A |
| 9/30/2022 | 497 | -4 | -31 | -28 | N/A |
| 6/30/2022 | 500 | -4 | -26 | -23 | N/A |
| 3/31/2022 | 510 | 12 | -16 | -12 | N/A |
| 12/31/2021 | 515 | 21 | -11 | -8 | N/A |
| 9/30/2021 | 512 | 28 | 14 | 15 | N/A |
| 6/30/2021 | 502 | 28 | 11 | 11 | N/A |
| 3/31/2021 | 466 | 23 | 21 | 21 | N/A |
| 12/31/2020 | 450 | 18 | 18 | 20 | N/A |
| 9/30/2020 | 447 | 20 | 10 | 13 | N/A |
| 6/30/2020 | 449 | 25 | 12 | 15 | N/A |
| 3/31/2020 | 461 | 27 | -11 | -8 | N/A |
| 12/31/2019 | 453 | 28 | -2 | -1 | N/A |
| 9/30/2019 | 436 | 31 | 9 | 10 | N/A |
| 6/30/2019 | 430 | 30 | 14 | 14 | N/A |
| 3/31/2019 | 409 | 28 | 21 | 22 | N/A |
| 12/31/2018 | 394 | 27 | N/A | 18 | N/A |
| 9/30/2018 | 383 | 26 | N/A | 16 | N/A |
| 6/30/2018 | 358 | 22 | N/A | 14 | N/A |
| 3/31/2018 | 352 | 23 | N/A | 30 | N/A |
| 12/31/2017 | 345 | 20 | N/A | 26 | N/A |
| 9/30/2017 | 329 | 14 | N/A | 1 | N/A |
| 6/30/2017 | 325 | 12 | N/A | -2 | N/A |
| 3/31/2017 | 312 | 10 | N/A | -7 | N/A |
| 12/31/2016 | 306 | 10 | N/A | -9 | N/A |
| 9/30/2016 | 310 | 12 | N/A | 4 | N/A |
| 6/30/2016 | 300 | 10 | N/A | 5 | N/A |
| 3/31/2016 | 300 | 11 | N/A | -2 | N/A |
| 12/31/2015 | 298 | 11 | N/A | -3 | N/A |
| 9/30/2015 | 294 | 12 | N/A | -6 | N/A |
| 6/30/2015 | 285 | 13 | N/A | -5 | N/A |
| 3/31/2015 | 284 | 13 | N/A | -2 | N/A |
| 12/31/2014 | 272 | 12 | N/A | 3 | N/A |
| 9/30/2014 | 261 | 10 | N/A | 5 | N/A |
| 6/30/2014 | 254 | 7 | N/A | 6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NNH's forecast earnings growth is above the savings rate (1.3%).
Earnings vs Market: Insufficient data to determine if NNH's earnings are forecast to grow faster than the Swedish market
High Growth Earnings: Insufficient data to determine if NNH's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if NNH's revenue is forecast to grow faster than the Swedish market.
High Growth Revenue: Insufficient data to determine if NNH's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NNH's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/20 08:16 |
| End of Day Share Price | 2025/05/20 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
New Nordic Healthbrands AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.